Publicação
Establishing a new state-of-the-art life science research institute: opportunities and barriers of biobanking
| Resumo: | The newly established Nova Institute for Medical Systems Biology (NIMSB) in Portugal aims at becoming a leader in medical systems biology. This work project aims at exploring the challenges and opportunities along four key conceptual components of the NIMSB, which are local partnerships, biobanking, clinical trials, and industry collaborations. For the analysis, insights from 45 interview partners and from additional research were consolidated. The results displayed four key strategies for the institute regarding the key components. The NIMSB should strongly engage in local and global collaborations from the beginning. A hybrid biobanking model should be implemented and cutting-edge technologies are advised to be utilized for support in clinical trials. Lastly, innovation and entrepreneurship should be forstered through long-term industry partnerships. Altogether, this will lay a robust foundation for NIMSB's future growth and impact in the research ecosystem. |
|---|---|
| Autores principais: | Wense, Mariella Von Der |
| Assunto: | Research organizations Biobanking Biological repositories Precision medicine Sample collection Specimens collection |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | The newly established Nova Institute for Medical Systems Biology (NIMSB) in Portugal aims at becoming a leader in medical systems biology. This work project aims at exploring the challenges and opportunities along four key conceptual components of the NIMSB, which are local partnerships, biobanking, clinical trials, and industry collaborations. For the analysis, insights from 45 interview partners and from additional research were consolidated. The results displayed four key strategies for the institute regarding the key components. The NIMSB should strongly engage in local and global collaborations from the beginning. A hybrid biobanking model should be implemented and cutting-edge technologies are advised to be utilized for support in clinical trials. Lastly, innovation and entrepreneurship should be forstered through long-term industry partnerships. Altogether, this will lay a robust foundation for NIMSB's future growth and impact in the research ecosystem. |
|---|